Bioimpedance analyzers market seen reaching $1.28B by 2030

The bioimpedance analyzers market is projected to grow from $0.67 billion in 2025 to $1.28 billion by 2030, driven by obesity concerns, personalized health monitoring and wider use in clinical and fitness settings. North America leads today, while Asia-Pacific is expected to grow fastest.

Why it matters: - Bioimpedance analyzers are gaining traction because they offer quick, non-invasive body composition analysis for fitness, clinical and wellness use. - The market’s projected rise to $1.28 billion by 2030 signals sustained demand for tools that help track fat, muscle and water content. - Rising obesity and metabolic disorders are increasing demand for measurement devices that support personalized treatment and monitoring.

What happened: - The Business Research Company released a market intelligence report on the global bioimpedance analyzers market. - The report estimates the market will grow from $0.67 billion in 2025 to $0.76 billion in 2026. - The report projects the market will reach $1.28 billion by 2030, at a CAGR of 13.9%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Bioimpedance analyzers measure the electrical impedance of biological tissues to assess body composition. - The devices send a small, safe electrical current through the body and measure resistance across different tissue types. - The measurement provides information on body fat, muscle and water content. - Historic growth has been supported by higher fitness and wellness awareness, broader use in sports and rehabilitation, early adoption in hospitals and nutrition clinics, and the expansion of fitness clubs and wellness centers. - The forecast period is supported by rising obesity and metabolic disorders, demand for personalized health and fitness monitoring, and greater use of wireless and connected analyzers. - The report also points to wider use of multi-frequency devices, home-based and remote health monitoring, and segmental and whole-body measurement technologies. - The market coverage includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report includes a free sample and the full market report through the company’s sample page and the full report.

Between the lines: - The market outlook reflects a broader shift toward non-invasive monitoring that can be used outside traditional clinical settings. - Wireless and connected devices suggest manufacturers are targeting more continuous tracking and remote care use cases. - North America’s lead points to mature healthcare demand, while Asia-Pacific’s growth outlook tracks rising health spending and obesity rates.

What's next: - Continued growth is expected as obesity rates rise and consumers seek more personalized health tracking. - Broader adoption in hospitals, clinics, gyms and home settings is likely to drive device innovation. - Multi-frequency, segmental and connected systems are likely to shape the next phase of product development. - The company identified contact points for sales and media inquiries, including Saumya Sahay at marketing@tbrc.info and Oliver Guirdham through The Business Research Company.